SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing high volatility as investors react to a new exclusive partnership with Proximity Media while debating the company's long-term growth and valuation. The community is actively tracking potential support levels and institutional activity, with many split between those buying the dip for a potential reversal and bears betting on further downside following recent share price pressure.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing significant selling pressure and heightened volatility as retail investors debate whether the stock is undergoing a fundamental valuation reset or a targeted institutional shakeout. While some community members highlight strong long-term revenue growth and ongoing government contract wins, others are focused on technical support levels and the stock's recent disconnect from broader software sector rallies.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is capturing significant market attention as it prepares for its official inclusion in the Nasdaq-100 index, which investors expect will trigger substantial institutional buying and passive fund inflows. The community remains focused on the company's massive multi-billion dollar contract backlog and strong performance in AI infrastructure benchmarks, fueling ongoing debates about its long-term valuation compared to sector peers.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is currently trending as investors weigh its aggressive infrastructure spending and AI cloud integration against broader market concerns regarding hyperscaler capital expenditure. While the community is actively debating the company's long-term valuation and data center efficiency, sentiment remains mixed between those viewing the stock as a discounted long-term compounding opportunity and those frustrated by its recent price underperformance relative to other tech giants.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is facing intensified scrutiny as investors weigh the impact of its significant capex spending and potential talent migration against its dominant position in AI and cloud infrastructure. Community sentiment remains split between long-term confidence in the company's AI-integrated ecosystem and immediate concerns over market volatility and sector-wide risk-off moves.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing intense investor frustration as the stock experiences a prolonged downtrend, with the community actively debating whether the current sell-off is an overreaction to high capital expenditure on AI or a fundamental shift in the company's long-term growth prospects. Discussions are dominated by concerns over stagnant price action, disappointing performance compared to other large-cap tech peers, and anxiety regarding how the company's heavy AI spending will ultimately impact free cash flow.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares are facing intense selling pressure and high volatility amid concerns over brand perception, management changes, and recent controversies in China, leading to significant downward price adjustments. While many investors are expressing frustration over the steep decline from previous highs, others are debating whether the current valuation represents a deep-value opportunity or a sign of a long-term shift in consumer sentiment away from the brand.

HIVE Digital Technologies Ltd. engages in building a bridge between the digital currency and blockchain sector and traditional capital markets. The firm operates data centers for computing and mining cryptocurrencies, including Bitcoin and other coins. It owns and operates green energy-powered data center facilities in Canada, Sweden, and Iceland. The company was founded on June 24, 1987 and is headquartered in San Antonio, TX.

HIVE Digital Technologies Ltd.

HIVE Digital Technologies Ltd

HIVE Digital Technologies is seeing significant momentum as investors re-rate the stock from a legacy miner into an AI compute infrastructure play, fueled by a landmark sovereign AI contract and positive performance benchmarks from its Paraguay operations. Community sentiment is heavily focused on the company's aggressive infrastructure build-out and expanding cadence of partnerships, with many discussing the long-term potential of its data center pivot.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is trending as investors react to its massive equity offering and continued capital-intensive expansion into data centers and AI infrastructure. The community remains divided, with many debating whether these expenditures represent a strategic moat or an unsustainable cash burn that risks long-term shareholder dilution.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor activity and volatility as the community focuses on upcoming clinical trial catalysts, including the initiation of their phase 3 lung cancer program and anticipation of a major buyout opportunity. Investors are closely monitoring institutional accumulation and potential short-covering as they interpret recent tape movements and manufacturing progress as indicators of imminent, value-driving news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet...

4 Biotech Stocks Investors Should Watch in 2026

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position LQDA, IMNM, STOK and IMCR well in this volatile sector. 

Stoke Therapeutics (STOK) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Stoke Therapeutics (STOK) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Stoke Therapeutics, Inc. (STOK) Reports Q1 Results and Business Updates

Stoke Therapeutics, Inc. (STOK) Reports Q1 Results and Business Updates...

Stoke Therapeutics to Present at Upcoming Investor Conferences in June

Is it a Good Idea to Invest in Stoke Therapeutics Stock Now?

STOK rides high as zorevunersen advances in late-stage Dravet syndrome studies and heads toward FDA filing plans.

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational...

Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates

Stoke Therapeutics (STOK) delivered earnings and revenue surprises of +0.94% and +18.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates

Recursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue Estimates

Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of +25.42% and -60.08%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Stoke Therapeutics Inc

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.77	--	--	N/A
Q1 '26	-$0.81	-$0.79	2.17%	BEAT
Q4 '25	-$0.93	--	--	N/A
Q3 '25	-$0.57	-$0.65	-14.40%	MISSED
Q2 '25	-$0.51	-$0.40	21.88%	BEAT

STOKStoke Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest STOK News